Based on the provided sources, there are patient assistance programs available for Vascepa, a prescription medication used to lower triglyceride levels in adult patients.

Firstly, according to the drug patent watch website [1], Vascepa is a medication produced by Amarin Pharma, Inc. and its patent is set to expire in 2029. Although this source does not directly mention patient assistance programs, it provides context for the medication and its manufacturer.

The Vascepa official website [2] offers a savings program for Vascepa, which can help eligible patients save on their prescription. The program provides a savings card that can reduce out-of-pocket costs for Vascepa. The website states that eligible patients can pay as little as $0 for a 30-day supply and $5 for a 90-day supply.

Furthermore, the Vascepa Copay Savings Program website [3] provides detailed information on how to enroll in the program and start saving on Vascepa. The website states that the program is available to patients with commercial insurance, and it can be used at any participating pharmacy.

In summary, there are patient assistance programs available for Vascepa, a medication used to lower triglyceride levels in adult patients. The Vascepa Savings Program and the Vascepa Copay Savings Program are two options for eligible patients to save on their prescription.

Sources:
[1] <https://www.drugpatentwatch.com/p/tradename/VASCEPA>
[2] <https://www.vascepa.com/getting-started/vascepa-savings/>
[3] <https://vascepa.copaysavingsprogram.com/>